Excelsior Integrated Medical Group, PLLC
Excelsior Integrated Medical Group, PLLC was paid $57.70M by Medicaid between Jan 2018 and Dec 2024, across 373 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 32% of everything it billed.
33Billing provider infoEXCELSIOR INTEGRATED MEDICAL GROUP, PLLC
NEW YORK, NY 10013
NEW YORK, NY 10013
33aNPI1689009854assigned 09/06/2013
33bProvider typeSpecialist
28Total paid$57.70M
24GClaims2,252,351
24DCodes billed373
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in New York
Rank by total paid#3 of 1,221
Median peer was paid$45K
This provider vs. median1,276×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official HALL, GEORGE controls 15+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 223,886 | $6.75M | |
| 2019 | 318,395 | $8.37M | |
| 2020 | 331,436 | $7.38M | |
| 2021 | 475,023 | $13.81M | |
| 2022 | 588,146 | $16.93M | |
| 2023 | 288,871 | $4.37M | |
| 2024incomplete | 26,594 | $93K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 32% | 313,202 | 245,385 | $18.39M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.7% | 50,261 | 46,935 | $4.45M |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 5.2% | 34,310 | 34,117 | $2.98M |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 4.3% | 21,529 | 21,517 | $2.50M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 2.7% | 3,006 | 2,981 | $1.55M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2.0% | 5,584 | 5,580 | $1.13M |
| 99442 | 2.0% | 19,618 | 18,363 | $1.13M | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.8% | 10,089 | 10,074 | $1.04M |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 1.7% | 6,503 | 6,502 | $1.00M |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.7% | 7,959 | 7,957 | $994K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.7% | 14,259 | 14,201 | $991K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.5% | 30,921 | 30,805 | $849K |
361 more codes
| 76536 | 1.5% | 8,203 | $844K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1.2% | 1,366 | $698K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.2% | 18,645 | $688K |
| G0444 | Annual depression screening, 5 to 15 minutes | 1.1% | 55,109 | $634K |
| 99204 | Doctor's office visit, new patient (more involved) | 1.1% | 3,879 | $618K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.1% | 3,804 | $613K |
| 93000 | 1.0% | 47,430 | $600K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 7,990 | $573K |
| 76641 | <1% | 4,024 | $545K | |
| 86328 | <1% | 15,216 | $536K | |
| 88312 | <1% | 2,404 | $461K | |
| 99497 | <1% | 6,003 | $418K | |
| 90756 | <1% | 19,915 | $386K | |
| 75574 | <1% | 1,213 | $380K | |
| 93229 | <1% | 603 | $373K | |
| 74183 | <1% | 851 | $357K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 42,889 | $351K |
| 88313 | <1% | 2,246 | $344K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 38,762 | $332K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 679 | $322K |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 21,982 | $321K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 3,503 | $315K |
| 80053 | Comprehensive metabolic panel | <1% | 35,822 | $312K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 8,445 | $305K |
| 92250 | <1% | 7,677 | $295K | |
| 80061 | Lipid panel | <1% | 44,313 | $265K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 8,630 | $263K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 988 | $253K |
| 76830 | Ultrasound, transvaginal | <1% | 2,071 | $233K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 27,702 | $230K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 1,823 | $227K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 2,153 | $201K |
| 71250 | <1% | 1,174 | $196K | |
| 93880 | <1% | 1,212 | $195K | |
| 94010 | <1% | 6,554 | $191K | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 61,593 | $187K |
| 90688 | <1% | 10,379 | $183K | |
| 92060 | <1% | 2,462 | $163K | |
| 84439 | <1% | 20,264 | $145K | |
| 93224 | <1% | 1,650 | $139K | |
| 84480 | <1% | 24,792 | $132K | |
| 77080 | <1% | 2,621 | $123K | |
| 76770 | <1% | 1,270 | $119K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 343 | $118K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 4,160 | $118K |
| 93351 | <1% | 528 | $112K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 180 | $112K |
| 92083 | <1% | 1,717 | $111K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 34,091 | $109K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 675 | $105K |
| 88342 | <1% | 1,200 | $105K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | <1% | 3,355 | $104K |
| 84153 | <1% | 6,004 | $103K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 1,033 | $99K |
| 99441 | <1% | 5,651 | $92K | |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | <1% | 6,748 | $91K |
| 72100 | <1% | 2,400 | $90K | |
| 93015 | <1% | 1,331 | $88K | |
| 80050 | General health panel | <1% | 5,191 | $88K |
| 99051 | <1% | 25,096 | $87K | |
| 92015 | Determination of refractive state | <1% | 4,405 | $85K |
| 0064A | <1% | 2,313 | $85K | |
| 71271 | <1% | 593 | $78K | |
| 86780 | <1% | 6,466 | $75K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 250 | $74K |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 330 | $72K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 3,711 | $66K |
| 82607 | <1% | 6,524 | $60K | |
| 93978 | <1% | 369 | $59K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 671 | $57K |
| 90750 | <1% | 516 | $57K | |
| 83013 | <1% | 694 | $57K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 140 | $56K |
| 99406 | <1% | 6,212 | $55K | |
| 82746 | <1% | 6,045 | $55K | |
| 72050 | <1% | 1,084 | $54K | |
| 84550 | <1% | 13,754 | $54K | |
| 10005 | <1% | 360 | $54K | |
| 73562 | <1% | 1,153 | $53K | |
| 87340 | <1% | 5,826 | $51K | |
| 99490 | Ccm add 20min | <1% | 1,549 | $49K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,094 | $49K |
| 0012A | <1% | 1,289 | $47K | |
| 77065 | Tomosynthesis, mammo | <1% | 381 | $47K |
| 82947 | <1% | 11,957 | $47K | |
| 99386 | <1% | 345 | $47K | |
| 0011A | <1% | 1,296 | $47K | |
| 93970 | <1% | 272 | $46K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 621 | $45K |
| 3074F | <1% | 43,017 | $43K | |
| 94060 | <1% | 997 | $43K | |
| 3078F | <1% | 41,106 | $43K | |
| 86706 | <1% | 5,490 | $42K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,536 | $42K |
| 80076 | <1% | 6,363 | $41K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,246 | $41K |
| H0049 | Alcohol and/or drug screening | <1% | 15,594 | $40K |
| 82728 | <1% | 3,611 | $40K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,972 | $40K |
| 88173 | <1% | 382 | $39K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 234 | $39K |
| 82043 | <1% | 9,363 | $39K | |
| 97161 | <1% | 716 | $39K | |
| 99443 | <1% | 584 | $38K | |
| 82570 | <1% | 9,357 | $38K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,962 | $37K |
| 99385 | <1% | 560 | $37K | |
| 90746 | <1% | 588 | $37K | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 161 | $36K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 478 | $35K |
| 84436 | <1% | 7,968 | $35K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,099 | $33K |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | <1% | 4,877 | $32K |
| 82105 | <1% | 4,629 | $31K | |
| 97014 | <1% | 1,841 | $30K | |
| 97162 | <1% | 602 | $30K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 107 | $29K |
| 90715 | <1% | 803 | $28K | |
| 90651 | <1% | 138 | $27K | |
| 90674 | <1% | 1,325 | $27K | |
| 84481 | <1% | 3,224 | $26K | |
| 96367 | <1% | 414 | $25K | |
| 99397 | <1% | 355 | $24K | |
| 76775 | <1% | 408 | $24K | |
| 36410 | <1% | 6,961 | $23K | |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | <1% | 161 | $23K |
| 76512 | <1% | 386 | $22K | |
| 99401 | <1% | 3,621 | $22K | |
| 81003 | <1% | 17,269 | $22K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 81,940 | $21K |
| 74170 | <1% | 75 | $21K | |
| 94621 | <1% | 152 | $21K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 546 | $21K |
| 93320 | <1% | 315 | $18K | |
| 0134A | <1% | 477 | $18K | |
| 81001 | <1% | 6,123 | $18K | |
| 94729 | <1% | 381 | $17K | |
| 97032 | <1% | 1,628 | $16K | |
| 81005 | <1% | 9,080 | $16K | |
| 73630 | <1% | 406 | $15K | |
| 74178 | <1% | 46 | $15K | |
| 68761 | <1% | 92 | $14K | |
| 93925 | <1% | 74 | $14K | |
| 90686 | <1% | 1,069 | $14K | |
| 86708 | <1% | 1,696 | $14K | |
| G0008 | Administration of influenza virus vaccine | <1% | 4,186 | $14K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 49 | $14K |
| 96127 | <1% | 10,264 | $14K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 556 | $14K |
| 94727 | <1% | 384 | $13K | |
| 90732 | <1% | 108 | $13K | |
| 81000 | <1% | 3,633 | $13K | |
| 94375 | <1% | 352 | $12K | |
| 3079F | <1% | 11,976 | $12K | |
| 93228 | <1% | 613 | $12K | |
| 92588 | <1% | 215 | $11K | |
| 93325 | <1% | 315 | $11K | |
| 78268 | <1% | 161 | $10K | |
| 0031A | <1% | 264 | $10K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 52 | $10K |
| 82274 | <1% | 4,704 | $10K | |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 307 | $9K |
| 99424 | <1% | 107 | $9K | |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | <1% | 26 | $9K |
| 46600 | <1% | 76 | $9K | |
| H0001 | Alcohol and/or drug assessment | <1% | 28,872 | $9K |
| 88172 | <1% | 309 | $9K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 73 | $9K |
| 1111F | <1% | 2,496 | $9K | |
| 73030 | <1% | 244 | $9K | |
| 0013A | <1% | 265 | $8K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 197 | $8K |
| 88108 | <1% | 306 | $8K | |
| 86580 | <1% | 1,398 | $8K | |
| 92133 | <1% | 218 | $8K | |
| 84378 | <1% | 984 | $8K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 67 | $8K |
| 93979 | <1% | 87 | $8K | |
| 0004A | <1% | 211 | $8K | |
| 3075F | <1% | 7,170 | $7K | |
| 93241 | <1% | 25 | $7K | |
| 3077F | <1% | 4,674 | $7K | |
| 77066 | Tomosynthesis, mammo | <1% | 42 | $7K |
| 86413 | <1% | 1,411 | $7K | |
| 88177 | <1% | 308 | $7K | |
| 83540 | <1% | 1,697 | $7K | |
| 92557 | <1% | 215 | $7K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 526 | $6K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 136 | $6K |
| H0050 | Alcohol and/or drug services, brief intervention, per 15 minutes | <1% | 1,588 | $6K |
| 83735 | <1% | 1,409 | $5K | |
| 0001A | <1% | 124 | $5K | |
| 72110 | <1% | 133 | $5K | |
| 87517 | <1% | 846 | $5K | |
| 72197 | <1% | 12 | $5K | |
| 83615 | <1% | 1,380 | $5K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 261 | $5K |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | <1% | 267 | $5K |
| 82977 | <1% | 1,221 | $5K | |
| 0002A | <1% | 121 | $5K | |
| 90658 | <1% | 350 | $5K | |
| 96417 | <1% | 48 | $5K | |
| 92020 | <1% | 166 | $5K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 96 | $4K |
| 92202 | <1% | 272 | $4K | |
| 68801 | <1% | 36 | $4K | |
| 90682 | <1% | 69 | $4K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 94 | $4K |
| 88160 | <1% | 72 | $4K | |
| 91200 | <1% | 121 | $4K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 427 | $3K |
| 92570 | <1% | 177 | $3K | |
| 76514 | <1% | 321 | $3K | |
| 74018 | <1% | 100 | $3K | |
| 82565 | <1% | 5,607 | $3K | |
| 0072A | <1% | 71 | $3K | |
| 84100 | <1% | 961 | $3K | |
| 81002 | <1% | 1,599 | $3K | |
| 97035 | <1% | 306 | $3K | |
| 3080F | <1% | 2,409 | $3K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 96 | $3K |
| 83014 | <1% | 1,340 | $3K | |
| 46930 | <1% | 13 | $2K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 2,110 | $2K |
| 99408 | <1% | 18,712 | $2K | |
| 72052 | <1% | 51 | $2K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 41 | $2K |
| 73610 | <1% | 61 | $2K | |
| 99407 | <1% | 98 | $2K | |
| 99205 | Prolong outpt/office vis | <1% | 12 | $2K |
| 1159F | <1% | 19,395 | $2K | |
| 1160F | <1% | 17,798 | $2K | |
| 96160 | <1% | 1,378 | $2K | |
| 72070 | <1% | 59 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 299 | $2K |
| 84520 | <1% | 716 | $2K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 13 | $2K |
| 87341 | <1% | 232 | $2K | |
| 99050 | <1% | 134 | $1K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 192 | $1K |
| 73564 | <1% | 27 | $1K | |
| 92134 | <1% | 36 | $1K | |
| 90846 | Family psychotherapy without the patient present, 50 minutes | <1% | 14 | $1K |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 103 | $1K |
| 82550 | <1% | 283 | $1K | |
| 87350 | <1% | 153 | $1K | |
| 85651 | <1% | 616 | $1K | |
| 83880 | <1% | 42 | $1K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 330 | $1K |
| 1170F | <1% | 4,370 | $1K | |
| 76857 | <1% | 24 | $1K | |
| 86803 | <1% | 124 | $1K | |
| 0071A | <1% | 28 | $1K | |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 30 | $1K |
| 82270 | <1% | 1,577 | $988.16 | |
| 90714 | <1% | 37 | $981.08 | |
| 76882 | <1% | 22 | $974.96 | |
| 3044F | <1% | 5,054 | $916.31 | |
| 92552 | <1% | 58 | $813.63 | |
| 86709 | <1% | 79 | $771.12 | |
| 90707 | <1% | 12 | $751.68 | |
| G9275 | Documentation that patient is a current non-tobacco user | <1% | 33,239 | $734.53 |
| 0044A | <1% | 16 | $560.00 | |
| 0124A | <1% | 13 | $531.16 | |
| 0521F | <1% | 4,627 | $504.00 | |
| 1125F | <1% | 3,162 | $463.00 | |
| 97803 | <1% | 3,276 | $412.66 | |
| 1126F | <1% | 3,293 | $387.00 | |
| 83550 | <1% | 119 | $383.15 | |
| 72220 | <1% | 13 | $381.68 | |
| 86592 | <1% | 123 | $367.27 | |
| 93040 | <1% | 43 | $344.21 | |
| S0257 | Counseling and discussion regarding advance directives or end of life care planning and decisions, with patient and/or surrogate (list separately in addition to code for appropriate evaluation and management service) | <1% | 3,960 | $320.25 |
| 88112 | <1% | 14 | $319.88 | |
| G9622 | Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method | <1% | 37,020 | $295.54 |
| 36416 | <1% | 1,040 | $272.40 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 605 | $264.04 |
| 82272 | <1% | 191 | $229.19 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 13 | $226.52 |
| 2023F | <1% | 829 | $204.00 | |
| 97164 | <1% | 17 | $191.02 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | <1% | 43,068 | $178.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | <1% | 40,463 | $172.50 |
| 86787 | <1% | 21 | $158.78 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 179 | $155.50 |
| 3061F | <1% | 535 | $128.10 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 8,680 | $121.00 |
| 99491 | Ccm add 20min | <1% | 31 | $105.36 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 26 | $104.37 |
| 99072 | <1% | 1,348 | $82.00 | |
| 1158F | <1% | 5,433 | $71.40 | |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 215 | $62.63 |
| 1157F | <1% | 4,879 | $44.40 | |
| A4556 | Electrodes, (e.g., apnea monitor), per pair | <1% | 502 | $33.92 |
| 94760 | <1% | 193 | $31.39 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 75 | $31.20 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 375 | $23.89 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | <1% | 6,750 | $21.00 |
| 3045F | <1% | 99 | $20.02 | |
| 3011F | <1% | 134 | $20.00 | |
| 99000 | <1% | 20,552 | $12.75 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | <1% | 62,626 | $5.01 |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | <1% | 5,914 | $3.00 |
| 91313 | <1% | 179 | $2.57 | |
| 3048F | <1% | 115 | $1.20 | |
| 1036F | <1% | 17,053 | $1.04 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | <1% | 12,640 | $1.01 |
| 2000F | <1% | 5,720 | $1.00 | |
| 91301 | <1% | 3,014 | $0.72 | |
| 3008F | <1% | 51,083 | $0.41 | |
| 91306 | <1% | 362 | $0.18 | |
| 1000F | <1% | 19,802 | $0.04 | |
| 3016F | <1% | 17,219 | $0.03 | |
| S9449 | Weight management classes, non-physician provider, per session | <1% | 701 | $0.02 |
| 3725F | <1% | 22,847 | $0.01 | |
| 3117F | <1% | 30 | $0.01 | |
| 3022F | <1% | 151 | $0.01 | |
| G9276 | Documentation that patient is a current tobacco user | 0% | 4,427 | $0.00 |
| G8476 | Most recent blood pressure has a systolic measurement of < 140 mmhg and a diastolic measurement of < 90 mmhg | 0% | 1,803 | $0.00 |
| 3050F | 0% | 749 | $0.00 | |
| 1032F | 0% | 1,035 | $0.00 | |
| G8482 | Influenza immunization administered or previously received | 0% | 1,464 | $0.00 |
| G9621 | Patient identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method and received brief counseling | 0% | 521 | $0.00 |
| 4004F | 0% | 737 | $0.00 | |
| 0556F | 0% | 175 | $0.00 | |
| G8753 | Most recent systolic blood pressure >= 140 mmhg | 0% | 788 | $0.00 |
| S9470 | Nutritional counseling, dietitian visit | 0% | 279 | $0.00 |
| 3288F | 0% | 318 | $0.00 | |
| 2022F | 0% | 198 | $0.00 | |
| G8477 | Most recent blood pressure has a systolic measurement of >= 140 mmhg and/or a diastolic measurement of >= 90 mmhg | 0% | 794 | $0.00 |
| 4158F | 0% | 707 | $0.00 | |
| 91300 | 0% | 63 | $0.00 | |
| 3015F | 0% | 49 | $0.00 | |
| 4013F | 0% | 243 | $0.00 | |
| S9441 | Asthma education, non-physician provider, per session | 0% | 12 | $0.00 |
| 1100F | 0% | 57 | $0.00 | |
| 3051F | 0% | 13 | $0.00 | |
| 91304 | 0% | 17 | $0.00 | |
| 4145F | 0% | 86 | $0.00 | |
| 3017F | 0% | 3,182 | $0.00 | |
| 1034F | 0% | 796 | $0.00 | |
| 3014F | 0% | 1,467 | $0.00 | |
| 1031F | 0% | 2,549 | $0.00 | |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 471 | $0.00 |
| G0102 | Prostate cancer screening; digital rectal examination | 0% | 444 | $0.00 |
| 4010F | 0% | 856 | $0.00 | |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | 0% | 1,579 | $0.00 |
| 4008F | 0% | 122 | $0.00 | |
| G8755 | Most recent diastolic blood pressure >= 90 mmhg | 0% | 530 | $0.00 |
| 4037F | 0% | 1,123 | $0.00 | |
| G9906 | Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) | 0% | 1,448 | $0.00 |
| 1101F | 0% | 319 | $0.00 | |
| 4000F | 0% | 511 | $0.00 | |
| G9459 | Currently a tobacco non-user | 0% | 718 | $0.00 |
| 3049F | 0% | 754 | $0.00 | |
| G8475 | Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy not prescribed, reason not given | 0% | 60 | $0.00 |
| 91303 | 0% | 243 | $0.00 | |
| 57410 | 0% | 81 | $0.00 | |
| H0002 | Behavioral health screening to determine eligibility for admission to treatment program | 0% | 93 | $0.00 |
| G8422 | Bmi not documented, documentation the patient is not eligible for bmi calculation | 0% | 17 | $0.00 |
| 1123F | 0% | 34 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHALL, GEORGE (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Eventus Wholehealth, PLLC | Concord, NC | $26.34M |
| Robeson Health Care Corporation | Lumberton, NC | $2.20M |
| Robeson Health Care Corporation | Pembroke, NC | $2.15M |
| Robeson Health Care Corporation | Fairmont, NC | $2.13M |
| Robeson Health Care Corporation | Red Springs, NC | $1.57M |
| Robeson Health Care Corporation | Maxton, NC | $1.49M |
| Robeson Health Care Corporation | Saint Pauls, NC | $1.23M |
| Robeson Health Care Corporation | Laurinburg, NC | $1.17M |
| Robeson Health Care Corporation | Lumberton, NC | $362K |
| Robeson Health Care Corporation | Star, NC | $207K |
| Eventus Value Care, LLC | Concord, NC | $201K |
| Robeson Health Care Corporation | Pembroke, NC | $44K |
| Robeson Health Care Corporation | Fairmont, NC | $28K |
| George Hall, MD, PC | New York, NY | $4K |
| George D. Hall, MD | Charlotte, NC | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.